A Novel Anti-EGFR mAb Ame55 with Lower Toxicity and Better Efficacy than Cetuximab When Combined with Irinotecan. 2019

Weiyi Qiu, and Chang Zhang, and Shuang Wang, and Xiaoyan Yu, and Qiong Wang, and Dadi Zeng, and Peng Du, and Jinling Ma, and Yiqiong Zheng, and Bo Pang, and Yunzhou Yu, and Feng Long, and Xiaobin Pang, and Zhiwei Sun
Antibody Engineering Group, Beijing Biotechnology Institute, 100071 Beijing, China.

To improve efficacy and minimize toxicity of EGFR inhibition treatment, we developed Ame55, a novel anti-EGFR IgG1 with lower affinity to EGFR than cetuximab (C225) from a human phage library. Ame55 had lower bioactivity than cetuximab in vitro but similar antitumor efficacy as cetuximab in vivo. Moreover, Ame55 was more efficacious than cetuximab in a Lovo cell xenograft tumor model when combined with irinotecan (CPT-11). Ame55 concentrates in the mouse xenograft tumor and has less toxicity than cetuximab in cynomolgus monkeys in an overdose study.

UI MeSH Term Description Entries
D008252 Macaca fascicularis A species of the genus MACACA which typically lives near the coast in tidal creeks and mangrove swamps primarily on the islands of the Malay peninsula. Burmese Long-Tailed Macaque,Crab-Eating Monkey,Cynomolgus Monkey,M. f. aurea,M. fascicularis,Macaca fascicularis aurea,Monkey, Crab-Eating,Monkey, Cynomolgus,Crab-Eating Macaque,Burmese Long Tailed Macaque,Crab Eating Macaque,Crab Eating Monkey,Crab-Eating Macaques,Crab-Eating Monkeys,Cynomolgus Monkeys,Long-Tailed Macaque, Burmese,Macaque, Burmese Long-Tailed,Macaque, Crab-Eating,Monkey, Crab Eating
D008297 Male Males
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D003412 Cricetulus A genus of the family Muridae consisting of eleven species. C. migratorius, the grey or Armenian hamster, and C. griseus, the Chinese hamster, are the two species used in biomedical research. Hamsters, Armenian,Hamsters, Chinese,Hamsters, Grey,Armenian Hamster,Armenian Hamsters,Chinese Hamster,Chinese Hamsters,Grey Hamster,Grey Hamsters,Hamster, Armenian,Hamster, Chinese,Hamster, Grey
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000068818 Cetuximab A chimeric monoclonal antibody that functions as an ANTINEOPLASTIC AGENT through its binding to the EPIDERMAL GROWTH FACTOR RECEPTOR, where it prevents the binding and signaling action of cell growth and survival factors. C225,Erbitux,IMC C225,IMC-C225,MAb C225
D000074322 Antineoplastic Agents, Immunological Antineoplastic agents containing immunological agents (e.g. MAbs). These pharmacologic preparations inhibit or prevent the proliferation of NEOPLASMS. Antineoplastic MAbs,Antineoplastics, Monoclonal Antibodies,Antineoplastics, Monoclonal Antibody,MAbs, Antineoplastic,Monoclonal Antibodies, Antineoplastic,Antibodies Antineoplastics, Monoclonal,Antineoplastic Monoclonal Antibodies,Immunological Antineoplastic Agents,Monoclonal Antibodies Antineoplastics,Monoclonal Antibody Antineoplastics

Related Publications

Weiyi Qiu, and Chang Zhang, and Shuang Wang, and Xiaoyan Yu, and Qiong Wang, and Dadi Zeng, and Peng Du, and Jinling Ma, and Yiqiong Zheng, and Bo Pang, and Yunzhou Yu, and Feng Long, and Xiaobin Pang, and Zhiwei Sun
September 2012, Journal of cancer research and clinical oncology,
Weiyi Qiu, and Chang Zhang, and Shuang Wang, and Xiaoyan Yu, and Qiong Wang, and Dadi Zeng, and Peng Du, and Jinling Ma, and Yiqiong Zheng, and Bo Pang, and Yunzhou Yu, and Feng Long, and Xiaobin Pang, and Zhiwei Sun
November 2021, Expert opinion on biological therapy,
Weiyi Qiu, and Chang Zhang, and Shuang Wang, and Xiaoyan Yu, and Qiong Wang, and Dadi Zeng, and Peng Du, and Jinling Ma, and Yiqiong Zheng, and Bo Pang, and Yunzhou Yu, and Feng Long, and Xiaobin Pang, and Zhiwei Sun
March 2024, Bioorganic & medicinal chemistry,
Weiyi Qiu, and Chang Zhang, and Shuang Wang, and Xiaoyan Yu, and Qiong Wang, and Dadi Zeng, and Peng Du, and Jinling Ma, and Yiqiong Zheng, and Bo Pang, and Yunzhou Yu, and Feng Long, and Xiaobin Pang, and Zhiwei Sun
March 2013, Clinical cancer research : an official journal of the American Association for Cancer Research,
Weiyi Qiu, and Chang Zhang, and Shuang Wang, and Xiaoyan Yu, and Qiong Wang, and Dadi Zeng, and Peng Du, and Jinling Ma, and Yiqiong Zheng, and Bo Pang, and Yunzhou Yu, and Feng Long, and Xiaobin Pang, and Zhiwei Sun
June 2012, Journal of controlled release : official journal of the Controlled Release Society,
Weiyi Qiu, and Chang Zhang, and Shuang Wang, and Xiaoyan Yu, and Qiong Wang, and Dadi Zeng, and Peng Du, and Jinling Ma, and Yiqiong Zheng, and Bo Pang, and Yunzhou Yu, and Feng Long, and Xiaobin Pang, and Zhiwei Sun
March 2011, HNO,
Weiyi Qiu, and Chang Zhang, and Shuang Wang, and Xiaoyan Yu, and Qiong Wang, and Dadi Zeng, and Peng Du, and Jinling Ma, and Yiqiong Zheng, and Bo Pang, and Yunzhou Yu, and Feng Long, and Xiaobin Pang, and Zhiwei Sun
September 2014, Targeted oncology,
Weiyi Qiu, and Chang Zhang, and Shuang Wang, and Xiaoyan Yu, and Qiong Wang, and Dadi Zeng, and Peng Du, and Jinling Ma, and Yiqiong Zheng, and Bo Pang, and Yunzhou Yu, and Feng Long, and Xiaobin Pang, and Zhiwei Sun
September 2009, Expert opinion on biological therapy,
Weiyi Qiu, and Chang Zhang, and Shuang Wang, and Xiaoyan Yu, and Qiong Wang, and Dadi Zeng, and Peng Du, and Jinling Ma, and Yiqiong Zheng, and Bo Pang, and Yunzhou Yu, and Feng Long, and Xiaobin Pang, and Zhiwei Sun
December 2010, Clinical colorectal cancer,
Weiyi Qiu, and Chang Zhang, and Shuang Wang, and Xiaoyan Yu, and Qiong Wang, and Dadi Zeng, and Peng Du, and Jinling Ma, and Yiqiong Zheng, and Bo Pang, and Yunzhou Yu, and Feng Long, and Xiaobin Pang, and Zhiwei Sun
August 2015, Cancer immunology research,
Copied contents to your clipboard!